about
1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profilingSocioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood PsychopathologyN-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals.Selfish brain and neuroprogression in bipolar disorder.First manic episode in a patient with breast cancer.Systematic review of N-acetylcysteine in the treatment of addictions.Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.Abnormalities in sleep patterns in individuals at risk for psychosis and bipolar disorder.Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis.Association of serum interleukin-6 with mental health problems in children exposed to perinatal complications and social disadvantage.Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample.Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course.Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample.Adipokines, metabolic dysfunction and illness course in bipolar disorder.Translation and adaptation of the Bipolar Prodrome Symptom Scale-Retrospective: Patient Version to Brazilian portuguese.Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder.Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study.Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders.Shorter leukocyte telomere length in patients at ultra high risk for psychosis.Serum copeptin in children exposed to maltreatment.Impaired glucose metabolism moderates the course of illness in bipolar disorder.Brain tumor in a patient with attenuated psychosis syndrome.Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder.Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report.Ten-year evolution of suicide rates and economic indicators in large Brazilian urban centers.An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics.The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries.NMR Spectroscopy Metabolomics Applied to Crack Cocaine Users and Patients with Schizophrenia: Similar Behavior but Different Molecular CausesContinuing lack of evidence for the psychotic subtyping of PTSDPopulation neuroscience: challenges and opportunities for psychiatric research in low- and middle-income countries
P50
Q33760065-F928EE5C-1FF3-4B03-9DEF-5A5A513FB918Q36094596-8CF412A4-9C92-4535-AF5C-AF72E71FA274Q38040254-AD9C582B-E6B5-49AD-BF2B-1BF29858E9B6Q38069777-61EFE6FB-D8D0-4B16-90C6-C524AC71A267Q38114249-61E450A0-921C-47BD-A82F-DCC22E41DC37Q38199954-5812127C-07E4-40C3-B796-A03FFB33FE3EQ38449239-B9529221-5A19-4565-9B95-608CEDB7FBB5Q38590558-BAFF8897-B05C-427F-9B9F-6C549D2581E0Q38841093-F5480144-A9FA-439A-B7A3-3BAC4AFD78D2Q39046720-774B98B5-6BD3-4D96-9AE8-598D4FFD3F68Q39711948-39561FEB-D53E-4349-8220-901EBC88C07AQ40512454-C2273E4A-AA17-4715-8396-1EF9E9AE006DQ40690554-19E8E7E1-1715-44D7-95FD-5B6FDB6B04FEQ40771842-1E7367E5-F3C8-495B-96AD-A96E4A476196Q40989400-613292C2-EC84-4159-B7AF-5DADA3110BD4Q41000405-F91E01E2-FB20-4688-A5F2-1C7F8CAEE102Q42509069-C6F3C909-3290-4418-A9F6-D267CAF6DFE8Q47297974-C3C6B5B5-36EA-4C9A-94E3-9FECCBB4E103Q47700075-7DBB63DA-D9D9-4AA8-82FC-7FA9192F71E9Q47781439-355F0CE8-8FA6-4E21-9320-B7E0642FE729Q48005541-94986FB8-83C7-4B72-9001-3816083ADBA7Q48064227-E9EA0F59-8D54-487A-BDFB-7CBBBA696F11Q48219068-FDD60DB2-2213-4A69-9C1E-4C20BE9C3A7BQ48344210-F47EB533-B0A5-49FB-ADF8-6062D562775EQ48589275-6DED9FC3-A89C-459C-A937-4574DE76134CQ48788276-4E1279EF-B9E9-4309-8CE6-15B884E59587Q50630406-120156DA-0410-46CF-B603-B1C3CE459105Q51148145-CCBBFF29-D213-44F5-A098-0283005CAE43Q52565175-8E9BDA44-4C76-4636-A45E-EF9C4C11B28AQ55048802-B7D77E8D-BFD1-42FC-B66A-753983D895C0Q60419193-5988E87D-713C-4BD0-9C13-6D2D13424C07Q60419208-CA9CAD82-03A6-48FE-B5C0-B43E209E2601Q91723151-F882A582-AF77-4FEA-BB1E-0783E6B7C51B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elson Asevedo
@ast
Elson Asevedo
@en
Elson Asevedo
@es
Elson Asevedo
@nl
type
label
Elson Asevedo
@ast
Elson Asevedo
@en
Elson Asevedo
@es
Elson Asevedo
@nl
prefLabel
Elson Asevedo
@ast
Elson Asevedo
@en
Elson Asevedo
@es
Elson Asevedo
@nl
P106
P21
P31
P496
0000-0002-3109-2695